3/11/2008

Janet Woodcock, acting director of the FDA's Center for Drug Evaluation and Research, will permanently assume the post and relinquish her duties as deputy commissioner and chief medical officer, the agency announced. The appointment comes amid criticisms of the agency's drug-approval process and safety oversight.

Related Summaries